Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Patent
1990-05-11
1992-11-24
Brown, Johnnie R.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
536 27, 536 28, 536 29, A61K 3170
Patent
active
051661950
ABSTRACT:
Methods for modulating the expression of the HIV tat gene are disclosed comprising contacting tat RNA with oligonucleotide or oligonucleotide analog which can bind with at least a portions of the RNA. In accordance with the preferred embodiments, oligonucleotides or oligonucleotide analogs are designed to bind to portions of the tat RNA which are of significance to the expression of the gene coding for said RNA. In accordance with a preferred embodiment, methods of treatment of human immunodeficiency virus are disclosed.
REFERENCES:
patent: 4959463 (1990-09-01), Froehler et al.
S. Argawal, J. Goodchild, M. P. Civeira, A. H. Thornton, P. S. Sarin, P. C. Zamecnik, Proc. Nat'l Acad. Sci. USA 85, 7079 (1988).
S. Agarwal, T. Ikeuchi, D. Sun, P. S. Sarin, A. Konopka, J. Maizel, Proc. Nat'l Acad. Sci. USA 86, 7790 (1989).
B. Berkhout, Cell 59, 273 (1989).
H. M. Buck, L. H. Koole, M. H. P. van Gendersen, L. Smith, J. L. M. C. Green, S. Jurriaans and J. Goudsmit. Science 248, 208-212 (1990).
S. Feng, E. C. Holland, Nature 334, 165 (1988).
J. A. Garcia, D. Harrich, E. Soultanakis, F. Wu, R. Mitsuyasu, R. B. Gaynor, EMBO J. 8, 765 (1989).
J. Goodchild, S. Agrawal, M. P. Civeira, P. S. Sarin, D. Sun, P. C. Zamecnik, Proc. Nat'l. Acad. Sci. USA 85, 5507 (1988).
W. A. Haseltine, F. Wong-Staal, Scientific American Oct., 52 (1988).
P. Henthorn, P. Zervos, M. Raducha, H. Harris, T. Kadesch, Proc. Nat'l. Acad. Sci. USA 85, 6342 (1988).
Michael F. Laspia, Andrew, P. Rice, Michael, B. Matthews, Cell 59, 283 (1989).
R. L. Letsinger, G. R. Zhang, D. K. Sun, T. Ikeuchi, P. S. Sarin, Proc. Nat'l. Acad. Sci. USA 86, 6553 (1989).
D. S. Loose-Mitchell, TIPS, vol. 9, pp. 45-47 (1988).
C. J. Marcus-Sekura, Anal. Biochemistry, vol. 172, 289-295 (1988).
M. Matsukura, K. Shinozuka, G. Zon, et al. Proc. Natl. Acad. Sci. USA 84, 7706 (1987).
K. Mori, C. Boiziau, C. Cazenave, et al., Nucleic Acids Res. 17, 8207 (1989).
P. S. Sarin, S. Agrawal, M. P. Civeira, J. Goodchild, T. Ikeuchi, P. C. Zamecnik, Proc. Nat'l. Acad. Sci. USA 85, 7448 (1988).
Philip, A. Sharp, Robert, A. Marciniak, Cell 59, 229 (1989).
S. Shibahara, S. Mukai, H. Morisawa, H. Nakashima, S. Kobayashi, N. Yamamoto, Nucl. Acids Res. 17, 239 (1989).
C. A. Stein & J. S. Cohen, Cancer Research, vol. 48, pp. 2659-2668 (1988).
M. Stevenson, P. L. Iversen, J. Gen. Virol. 70, 2673 (1989).
A. R. Van der Krol, J. N. Mol, & A. R. Stuitje, BioTechniques, vol. 6, pp. 958-973 (1988).
J. Walder, Genes & Development, vol. 2, pp. 502-504 (1988).
J. A. Zaia, J. J. Rossi, G. J. Murakawa, P. A. Spallone, D. A. Stephens, B. E. Kaplan, J. Virol, 62, 3914 (1988).
G. Zon, Pharmaceutical Research, vol. 5, pp. 539-549 (1988).
P. C. Zamecnik, J. Goodchild, Y. Taguchi, P. S. Sarin, Proc. Nat'l. Acad. Sci. USA 83, 4143 (1986).
G. Zon, Journal of Protein Chemistry, vol. 6, pp. 131-145 (1987).
Brown Johnnie R.
Crane L. Eric
ISIS Pharmaceuticals Inc.
LandOfFree
Antisense inhibitors of the human immunodeficiency virus phospho does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antisense inhibitors of the human immunodeficiency virus phospho, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antisense inhibitors of the human immunodeficiency virus phospho will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-922001